Preparation and Statistical Modeling of Solid Lipid Nanoparticles of Dimethyl Fumarate for Better Management of Multiple Sclerosis

Advanced Pharmaceutical Bulletin
Smriti Ojha, Babita Kumar

Abstract

Purpose: The objective of this study was to synthesize and statistically optimize dimethyl fumarate (DMF) loaded solid lipid nanoparticles (SLNs) for better management of multiple sclerosis (MS). Methods: SLNs were formulated by hot emulsion, ultrasonication method and optimized with response surface methodology (RSM). A three factor and three level box-behnken design was used to demonstrate the role of polynomial quadratic equation and contour plots in predicting the effect of independent variables on dependent responses that were particle size and % entrapment efficiency (%EE). Results: The results were analyzed by analysis of variance (ANOVA) to evaluate the significant differences between the independent variables. The optimized SLNs were characterized and found to have an average particle size of 300 nm, zeta potential value of -34.89 mv and polydispersity index value < 0.3. Entrapment efficiency was found to be 59% and drug loading was 15%. TEM microphotograph revealed spherical shape and no aggregation of nanoparticles. In-vitro drug release profile was an indicative of prolonged therapy. In-vivo pharmacokinetic data revealed that the relative bioavailability was enhanced in DMF loaded SLNs in Wistar rats. Conclusi...Continue Reading

References

Apr 1, 2000·Drug Development and Industrial Pharmacy·Q Yang, G Owusu-Ababio
Sep 28, 2000·The New England Journal of Medicine·J H NoseworthyB G Weinshenker
Dec 6, 2000·Advanced Drug Delivery Reviews·M J Lawrence, G D Rees
Sep 21, 2002·Pharmaceutical Research·Jean-Christophe OlivierWilliam M Pardridge
Apr 28, 2004·Advanced Drug Delivery Reviews·S A WissingR H Müller
Dec 29, 2004·Journal of Drug Targeting·Paul R LockmanDavid D Allen
Jul 11, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·YiFan LuoJing Qin
Sep 5, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·A A AttamaC C Müller-Goymann
Oct 24, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Shruti ChopraSanjay K Motwani
Nov 7, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Sanjay K MotwaniRoop K Khar
Feb 8, 2008·International Journal of Pharmaceutics·Guihua HuangMingjin Dou
Oct 31, 2008·Lancet·Alastair Compston, Alasdair Coles
Apr 1, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Margaret F Bennewitz, W Mark Saltzman
Apr 29, 2009·AAPS PharmSciTech·Ramesh GannuMadhusudan Rao Yamsani
Jun 16, 2009·Nanomedicine : Nanotechnology, Biology, and Medicine·Madaswamy S MuthuSanjay Singh
Dec 30, 2009·International Journal of Pharmaceutics·Ziyaur RahmanMansoor A Khan
Feb 11, 2011·Biomedical Chromatography : BMC·Oriella GennariLucia Grumetto
Apr 20, 2012·Nanoscale Research Letters·Saad Tanvir, Li Qiao
Aug 22, 2012·AAPS PharmSciTech·Mark Sacchetti, Elham Nejati
Sep 26, 2013·Current Neurology and Neuroscience Reports·Ralf A Linker, Ralf Gold
Dec 24, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Elisabetta EspositoCarmelo Puglia
Jan 15, 2015·Therapeutic Advances in Neurological Disorders·Roberto Bomprezzi
Sep 1, 2015·International Journal of Biological Macromolecules·Luíse L ChavesSalette Reis
Apr 29, 2016·Advanced Pharmaceutical Bulletin·Parisa JourghanianMahdieh Mohammadnejad
Jan 29, 2017·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Diana L Vargas, William R Tyor

❮ Previous
Next ❯

Citations

Jan 27, 2020·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Maria Inês TeixeiraPaulo C Costa

❮ Previous
Next ❯

Methods Mentioned

BETA
equilibrium dialysis

Software Mentioned

Design Expert
Design Expert10

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.